Commissioning

This section of the website is currently under review. Please bear with us as we make changes to the current documents listed here for 2022/23

Link to NHS England Documents.

  • The Manual for Prescribed Specialised Services
  • Indications for NHS England Drugs List
  • NHS England Drug List changes

Commissioning Principles for Payment by Results Excluded Drugs and Devices

Appendix 1: Payment by Results Excluded Drugs and Devices list

Appendix 2: Agreement for Biosimilars

Appendix 3: Agreements for Payment by Results Excluded Drugs Delivered via Homecare

Appendix 4: Agreement for Insulin Pumps

Appendix 5: Agreement for Continuous Glucose Monitors (CGM)

Sequential Biologics: Interim policy v3.2

Direct acting oral anticoagulants (DOAC) – Commissioning recommendations for the national procurement of DOACs, which also refers to NICE NG196. The NICE frequently asked questions is also a useful resource.

SWL Growth Hormone Commissioning Policy Addendum 1

Insulin Pump Policy Where NICE Compliance not Demonstrated